Protected PCI

The Procedure

Protected PCI Enables Safe and Effective Treatment of High-Risk and Complex Patients

Benefits of Protected PCI include:

  • Improved outcomes through complete revascularization and reduction of repeat and staged procedures5
  • Improvement in ejection fraction and heart failure symptoms1
  • Significant reduction in the overall incidence of post-procedural acute kidney injury (AKI)2
  • Fewer hypotensive events during the procedure1
  • Reduction in peri-procedural MI and post-procedural MACCE3
  • Treatment options for patients ineligible for surgery4
  • Reduction in length of stay6

Unlocking Insights: Clinical Vignettes in High-Risk PCI Practice

 

Ejection Fraction Improvement with Complete Revascularization

Mitul Patel, MD, reviews the findings of the RESTORE EF study and a successful case of improved ejection fraction with complete revascularization.

Heart imaging in form of echocardiography and fluoroscopy

Specific Clinical Vignettes in High-Risk Protected Percutaneous Coronary Intervention

This article presents three case vignettes that provide practical insights and reinforce best practices. The authors emphasize that several cardiac and patient-related factors come into play when considering patients for Protected percutaneous coronary intervention (PCI).

 

Contemporary Practices for Impella®-Supported Complete Revascularization

Jason Wollmuth, MD, FACC, reviews the first case he enrolled in the RESTORE EF study, which highlights best practices and contemporary techniques to improve symptoms as well as ejection fraction in these complex patients.

 

Vasileios Panoulas, MD: Restoring EF in Daily Clinical Practice

Vasileios Panoulas, MD, PhD, FRCP, FESC, presents three case examples from his in daily clinical practice that illustrate LV improvement following Impella-supported PCI.

Resources

Read more about the procedural steps for the single-access technique that enables one access site for both the Impella CP® heart pump and an additional catheter.

Download PDF

Download the summary booklet and get access to European Protected PCI best practice insights.

Download Booklet

Explore more resources in our download section.

View Section

References

  1. O’Neill, W.W., et al. (2012). Circulation, 126(14), 1717-1727.
  2. Flaherty, M.P., et al. (2017). Circ Res, 120(4), 692-700.
  3. Dangas, G.D., et al. (2014). Am J Cardiol, 113(2), 222-228.
  4. Waldo, S.W., et al. (2014). Circulation, 130(25), 2295-2301.
  5. Burzotta, F., et al. (2019). J Interv Cardiol, 2019(5), 1-10.
  6. Maini, B., et al. (2014). Expert Rev Pharmacoecon Outcomes Res, 14(3), 403-416.

NPS-2628